tirzepatide diabetes type 1 Peptide of the Week: Tirzepatide, a Game Changer for 2 and Obesity Management Lilly Shows Tirzepatide Superiority in

[PMID: 2124297] PubMed record related to this compound for laboratory literature review

Many systems are asking for large increases for services (some requesting and receiving double-digit annual increases) and have shown a willingness to allow our contracts to expire

Patients already avoiding steroids due to hepatic or renal concerns should be evaluated carefully, as the combined metabolic load of an aggressive peptide protocol warrants individual assessment

Liver lipidomics analysis revealed the novel ameliorative mechanisms of L-Carnitine on high-fat diet-induced NAFLD Mice

Human vascular smooth muscle cells undergo vesicle-mediated calcification in response to changes in extracellular calcium and phosphate concentrations: a potential mechanism for accelerated vascular calcification in ESRD

INTERNATIONAL ROUNDUP (PharmaTimes, March 9-14) Regulatory Approvals: MHRA approved deuruxolitinib for severe alopecia areata NHS to offer fezolinetant for menopause hot flushes Clinical Trials: Aplagon dosed first patient in phase 2a peripheral arterial disease trial UCB reported bimekizumab superiority in psoriatic arthritis Kainova reported positive phase 1 data for DT-9081 in advanced solid tumours EnteroBiotix completed enrolment for EBX-102-02 trial in microbiome therapy Industry Appointments: Dr Michelle Morrow appointed CSO at Nucleome Dr Klaas Zuideveld named CEO at TECregen Rebecca Simmons appointed COO at Qureight KEY DATA POINTS SUMMARY Metric Value GLP-1 sales (MAT Feb 2026) 1,446 crore (177%) Stranded containers 40,000-45,000 Export cargo affected $1-1.5 billion War surcharge per container $3,000-5,000 Glycerin price increase 64% (Dec-Mar) Paracetamol API increase 26% (Dec-Mar) Polypropylene price increase 55/kg (since Dec) Universal NutriScience valuation 3,000 crore API exports (FY25) 41,500 crore API imports (FY25) 39,215 crore ABOUT THE INDIAN PHARMACEUTICAL INDUSTRY India is the "pharmacy of the world," supplying over 60% of global vaccine demand and 40% of generic medicines in the US